MedTrace Logo

Use of Inertial Units in Patient With Multiple Sclerosis (IMUSEP)

NCT06634225 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2026-03-12

No results posted yet for this study

Summary

The goal of this case control study is to evaluate the use of inertial navigation systems to detect and characterize early locomotor disorders in patients with multiple sclerosis (MS). The study aims to:

• Validate the contribution and inefficiency indexes obtained by the Trigno® Avanti Sensor inertial units, in comparison with indexes calculated with 3D motion analysis during walking and tandem in early-stage MS patients.

Researchers will compare MS patients, to healthy controls.

Conditions

Interventions

DIAGNOSTIC_TEST

Usual care (as recommended by the Haute Authorité de Santé (HAS)) and medical device test

Patients will receive the care they need, in line with HAS recommendations. They will be asked to perform two gait analysis tests on a three-dimensional platform, equipped with sensors (medical device).

DIAGNOSTIC_TEST

Usual care (as recommended by the Haute Authorité de Santé (HAS)) and medical device test

They will be asked to perform two gait analysis tests on a three-dimensional platform, equipped with sensors (medical device).

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • Lille Catholic University

    lead OTHER

Principal Investigators

  • Caroline MASSOT, PhD · Hôpital Saint-Philibert

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-08
Primary Completion
2025-12-19
Completion
2025-12-19

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06634225 on ClinicalTrials.gov